WATCH: CCM Professor in latest episode of Showcase with Barbara Kellar
Michael Unger joins Kellar to discuss Cincinnati's Fourth Annual Organ Festival
CET Cincinnati Public Television's arts and culture series Showcase with Barbara Kellar recently featured CCM Associate Professor of Keyboard (Organ and Harpsichord) Michael Unger in an episode with Robert Anderson, pastor of Covenant-First Presbyterian Church, to discuss Cincinnati's Fourth Annual Organ Festival.
Presented by Covenant-First Presbyterian Church in partnership with CCM, the Organ Festival features renowned organist Bruce Neswick in concert on Saturday, Feb. 26, and Sunday, Feb. 27. Neswick presents a master class at 9:30 a.m. on Feb. 26 and gives a recital at 4 p.m. on Feb. 27 — both events take place at Covenant-First Presbyterian Church, 717 Elm Street, Cincinnati, OH, 45202. Learn more about the Organ Festival.
Featured image at the top: Covenant-First Presbyterian Church. Photo/covfirstchurch.org
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.